$ADXN Addex Therapeutics Ltd ADR NASDAQ:ADXN Addex Therapeutics Ltd ADR
entry PT 5
Target PTs 9 --> 12 --> 20 and higher
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. T
0.0920 EUR
7.50 M EUR
436.13 K EUR
89.68 M
About Addex Therapeutics Ltd
Sector
Industry
CEO
Timothy Dyer
Website
Headquarters
Geneva
Founded
2002
ISIN
CH0029850754
FIGI
BBG000QVQ2N4
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Related stocks
APE/USDI believe the ape is getting ready to roar keep an eye on this one been watching it for some time now and believe it is ready to break out. There has been strong pressure both directions. Something is going to give most of the time it will pop up and burn a double play and then some. So stop on by a
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Addex Therapeutics Ltd stocks are traded under the ticker APE.
Yes, you can track Addex Therapeutics Ltd financials in yearly and quarterly reports right on TradingView.
APE net income for the last quarter is −1.54 M EUR, while the quarter before that showed −1.28 M EUR of net income which accounts for −19.92% change. Track more Addex Therapeutics Ltd financial stats to get the full picture.
No, APE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 24, 2025, the company has 2 employees. See our rating of the largest employees — is Addex Therapeutics Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Addex Therapeutics Ltd EBITDA is −2.49 M EUR, and current EBITDA margin is −608.50%. See more stats in Addex Therapeutics Ltd financial statements.
Like other stocks, APE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Addex Therapeutics Ltd stock right from TradingView charts — choose your broker and connect to your account.